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The Notch ligand delta-like 4 (DLL4) is known to fine-tune the CD4+ T cell cytokine 
response. DLL4 is expressed on the surface of antigen-presenting cells (APCs) in a 
MyD88-dependent manner. We found that DLL4 expression was upregulated on bone 
marrow progenitor cells and APCs in mice infected with BCG Mycobacterium. Transfer 
of DLL4+ progenitor cells from infected hosts resulted in an increase DLL4+ myeloid 
cells in the spleen, indicating that expression of the dll4 gene is propagated throughout 
hematopoiesis. We also found an increase in DLL4+ monocytes from individuals who 
were infected with Mycobacterium tuberculosis. In latent individuals, DLL4 expression 
correlated with increased cytokine production from T cells in response to PPD stimula-
tion. Finally, antibody blockade of DLL4 reduced T cell cytokine production from naïve 
T cells stimulated with antigen. These results demonstrate that the Notch ligand DLL4 
can influence T cell cytokine production in both humans and mice, and further reveal that 
expression of DLL4 is upregulated on early hematopoietic progenitors in response to 
chronic mycobacterial infection. These data suggest that widespread DLL4 expression 
may occur as a result of mycobacterial infection, and that this expression may alter CD4+ 
T cell responses to both previously encountered and novel antigens.
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inTrODUcTiOn
There is a growing body of evidence that the innate immune response to pathogen exposure can 
extend beyond the site of infection to alter both the rate of production and the function of newly 
formed white blood cells. For example, hematopoietic stem cells are known to respond to IFNγ with 
increased cell cycling (1–3), and bone marrow progenitor cells are known to respond to TLR agonists 
both in vitro and in vivo (4–7). Some of these changes may result in alterations in the innate immune 
response, a concept known as trained immunity (8, 9). In one study, trained immunity resulting 
from vaccination with bacille Calmette–Guerin was correlated with decreased morbidity resulting 
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from pathogen exposure, and this vaccination resulted in overall 
reduced mortality compared to unvaccinated individuals (10).
Although many of these studies focus on altered differentia-
tion of innate immune cells, there is little evidence that changes 
that occur at the stem cell level as a result of pathogen exposure 
can also alter the adaptive immune response. If changes relevant 
to adaptive immunity did occur in myeloid progenitor cells, 
these alterations would be most relevant in the adaptive immune 
response to chronic infection. Chronic infections are the result of 
immune responses that sub-optimally contain a pathogen at the 
expense of the host, resulting in tissue damage.
Mycobacterium tuberculosis (mTB) is responsible for 
approximately 1.5 million deaths each year and has infected 
between one-quarter and one-third of the world’s population 
(11–13), thus classifying this disease as a worldwide epidemic. 
The immune response to mTB is characterized by the forma-
tion of granulomas comprised of necrotic tissue and a milieu 
of cells that work in concert to contain the bacterium without 
effectively clearing it. Many researchers have demonstrated 
the importance of T cell participation in the containment of 
mTB (14–17). A recent study further suggests that the CD4+ 
T cell:antigen-presenting cell (APC) interaction plays a critical 
role in pathogen clearance and requires direct contact between 
the APC and the CD4+ T cell for an effective immune response 
(18). Other works have identified that APC-expressed costimu-
latory molecules aid in proper T cell activation in response to 
mycobacterial antigens (19, 20).
In the studies outlined below, we suggest that the Notch 
system provides an ideal target for long-term regulation of 
the adaptive immune system by APC in the setting of mTB 
infection. The Notch system consists of five ligands that sig-
nal promiscuously through four receptors to activate target 
gene transcription (21). The receptors Notch 1 and Notch 2 
are expressed at every stage of the T cell lifecycle, and Notch 
signaling has demonstrated importance in thymic maturation 
(22, 23), effector function (24, 25), and the formation and 
maintenance of immunological memory (26). The Notch ligand 
delta-like 4 (DLL4), which aids in T cell differentiation, is spe-
cifically upregulated on APCs only as a result of TLR signaling 
via a MyD88 pathway (27). Several studies have demonstrated 
the importance of DLL4 in the T cell response in multiple dis-
eases including respiratory syncytial virus (28), experimental 
autoimmune encephalomyelitis (29), type 1 diabetes (30), 
and the mycobacterial-elicited pulmonary immune response 
(31). DLL4 expression by APCs during viral infection reduced 
IL-4 and IL-13 production and increased production of IFNγ 
(28). In the mycobacterial- and EAE-driven responses, DLL4 
increased IL-17 production from CD4+ T cells (29, 31, 32). In 
type 1 diabetes, blockade of DLL4 decreased T cell activation 
and increased T regulatory cell differentiation (30). These data 
suggest that the DLL4 ligand can alter the T cell-driven immune 
response in a context-specific manner.
Here, we outline a pathway whereby DLL4, which is upregu-
lated in the lung during BCG mycobacteria infection in mice, is 
also increased systemically on the cell surface of APC as a result 
of exposure to this pathogen. Increased DLL4 protein can be 
observed on early progenitor cells in the bone marrow and on 
APCs in the spleen. We also demonstrate that DLL4 expression 
is maintained during short-term hematopoiesis in the absence 
of pathogenic stimuli using bone marrow chimeras. Finally, 
we demonstrate that DLL4 is upregulated on peripheral blood 
monocytes in a cohort of patients with latent or active TB infec-
tion and demonstrate that the presence of DLL4 on monocytes 
correlates with the T cell immune response in those patients that 
are latent tuberculosis infection (LTBI).
MaTerials anD MeThODs
Mycobacterial culture
BCG Mycobacterium (TICE strain) was obtained from Merck. 
Initial CFU was approximated by weight and cultures started in 
3.5 mL 7H9 media supplemented with OADC (BD Biosciences). 
Tubes were kept in a 37°C incubator and agitated daily for 
17  days. Cultures were spun at 3000 ×  g for 10  min and the 
supernatants removed. Pellets were resuspended in 3 mL of PBS 
with 0.5% Tween 80. Frozen stocks were prepared by mixing 20% 
of the BCG culture with 20% glycerol, 10% OADC, and 50% 7H9 
media. Cultures were stored at −80°C. CFU was determined by 
serial dilutions (100–1,000,000×) of frozen stocks and plating on 
7H11 media supplemented with 10% OADC.
To determine lung CFU, whole lungs were homogenized in 
1 mL of PBS and serial dilutions from 10 to 10,000× plated on 
7H11 agar supplemented with 10% OADC. Plates were incubated 
at 37°C for 16 days.
Mice
We used female C57BL/6 mice purchased from Taconic that 
were 6–8  weeks old at the beginning of the experiment. Mice 
were infected with 1.0 × 105–5.0 × 105 live Mycobacterium (BCG 
strain) by non-surgical intratracheal instillation.
Histology
Lungs were dissected and inflated with 10% normal buffered for-
malin and fixed in the same buffer overnight. Samples were then 
stored in 70% ethanol until processed. Histological analysis was 
performed on two serial 6-μm sections hematoxylin and eosin 
stained sections from each mouse.
RNA Extraction
RNA was extracted from 1.0 ×  107 splenic cells using TRIzol 
(Thermo Fisher Scientific) and 500  ng total RNA reverse 
transcribed using iScript (Bio-Rad, Hercules, CA, USA). 
QPCR was run on a Taqman 7500 analyzer using SYBR Green 
master mix and specific primers for murine dll4 (Forward: 
AGGTGCCACTTCGGTTACACAG, Reverse: CAATCACACA 
CTCGTTCCTCTCTTC). Gapdh was used as a control gene.
Flow cytometry
Murine
Flow cytometry was done on an LSR II with 488, 633, and 405 nM 
lasers. All mouse antibodies were purchased from BioLegend and 
used at a 1:200 dilution to stain between 1.0 × 104 and 1.0 × 107 
cells in 200 μL of FACS buffer (containing 1% FCS and 0.002 M 
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EDTA). In order to analyze only viable cells in the lung, the LIVE/
DEAD Fixable Violet Dead Cell Stain Kit (Life Technologies) was 
used according to manufacturer’s instructions. All lung samples 
were analyzed by first gating on viable cells and subsequently 
determining populations of interest. For lung flow cytometry, 
minced lungs were digested in 5 mL of a 1 mg/mL solution of 
Collagenase A (Roche) and 10 Kunitz units of DNAseI (Sigma-
Aldrich) in complete medium for 45 min at 37°C in a shaking 
incubator. Samples were subsequently passed 15× through a 
5-mL syringe with an 18 G needle, and filtered through 100 μM 
Nitex (Wild Life Supply Co., Yulee, FL, USA) to remove debris. 
The lung homogenate was centrifuged at 400 × g for 5 min, and 
the resulting cell pellet was resuspended in 2 mL of FACS buffer. 
200 μL of this suspension was used for flow cytometry staining in 
a 96-well plate. Spleen flow cytometry was performed by mincing 
the spleen and pressing through a 40 μM cell filter (BD) with the 
plunger from a 3-mL syringe and rinsing with FACS buffer. Spleen 
cells were centrifuged at 400 × g for 5 min and the resulting cell 
pellet resuspended in 3 mL of FACS buffer. For flow cytometry 
using bone marrow cells, one femur and one tibia were flushed 
with flow buffer using a 27-G needle, and cells were pressed 
through a cell filter, as described above. Cells were centrifuged 
and resuspended in 1 mL of FACS buffer and 200 μL was used for 
staining. To stain mouse cells, 1 μL of FC block and all specific 
antibodies were added simultaneously and incubated for 10 min 
at room temperature on an orbital shaker. Plates were centrifuged 
at 400 × g for 5 min, the supernatant aspirated, and an additional 
200 μL of FACS buffer added to wash the cells. After this wash step, 
the supernatant was aspirated and cells resuspended in 200 μL 
of formalin using a multichannel pipette. Cells were incubated 
for 10 min on an orbital shaker and then washed 2× in PBS, as 
described above. To determine cell counts, 10 μL of CountBright 
counting beads (Life Technologies) were added prior to running 
the samples on a flow cytometer. Cell counts were determined per 
manufacturer instructions.
For bone marrow chimera experiments, femurs, tibias, 
humerus, sacrum, lumbar, and thoracic vertebrae were dissected 
from each mouse and crushed using an autoclaved mortar and 
pestle in the presence of FACS buffer. Crushed bones were rinsed 
several times and subjected to additional crushing until no red 
matter was visible in the pestle. Cells were centrifuged as described 
and red blood cells lysed using AKC lysis buffer. The pellet was 
washed 3× with FACS buffer, resuspended in the remaining vol-
ume and then a biotinylated lineage depletion cocktail (FC block, 
anti-CD3, anti-CD19, anti-Nk1.1, anti-Ter119, and anti-GR1) 
was added, using 2 μL of each antibody per mouse. Cells were 
incubated for 10 min at 4°C and then anti-biotin beads (50 μL 
per mouse) (Miltenyi) were added. Cells were incubated for an 
additional 15 min at 4°C and then washed with 20 mL of FACS 
buffer. Cells were then passed through a CS column (Miltenyi) 
per manufacturer instructions (cells from three mice were pooled 
for one CS column). Flow through was centrifuged, the superna-
tant aspirated, and cells resuspended in the remaining volume of 
about 300 μL, and then stained with antibodies against c-kit APC, 
sca-1 Pe-Cy7, and also streptavidin FITC. LSK cells were sorted 
on a FACS Aria II with 488, 633, and 405 nM lasers.
Human
Participants for these studies were recruited from the Cape 
Town Area in South Africa and were all >18 years of age and 
sero-negative for HIV (33). LTBI was defined as a T cell cytokine 
response to ESAT-6 and/or CFP-10 with no previous history of 
TB disease or treatment. Diagnosis of active disease was based 
on symptoms, patient history, and sputum microscopy and/or 
culture. All patients with active disease were positive either by 
sputum-smear microscopy and/or M. tuberculosis growth in 
liquid culture of sputum. Cryopreserved PBMCs were thawed 
in a 37°C water bath and immediately added to 20 mL of warm 
RPMI. Cells were spun at 400 × g and resuspended in 1 mL of 
FACS buffer for human cells (PBS + 1% human serum albumin). 
About 200 μL of cells were used for analysis. Cells were stained 
with 1 μL CD14 Alexa700 (clone M5E2), 1 μL Dll4 PE (clone 
MHD4-46), 1 μL CD11b Pacific Blue (clone ICRF44), and 1 μL 
of a 1-mg/mL solution of Human IgG to block FC receptors. 
Cells were stained for 20 min at room temperature and the same 
procedure followed, as described above.
Bone Marrow Chimeras
Six-week-old C57Bl/6 mice were irradiated twice with 500 G 3 h 
apart on a rotating platform in a cesium irradiator. Cells were 
injected intravenously in 100  μL RPMI 3  h after the second 
irradiation.
cell culture
Naïve T cells were isolated from OT-II transgenic mice (The 
Jackson Laboratory, Bar Harbor, ME, USA) using Naïve Cell 
Isolation Kit II from Miltenyi. APCs from BCG infected and 
naïve mice were obtained by making a single-cell suspension 
from the pooled spleens of three mice. Red blood cells were lysed 
using AKC buffer, and cells were washed 2× in FACS buffer. Cells 
were then resuspended in 500  μL FACS buffer and incubated 
with 50 μL of an antibody cocktail containing equal proportions 
of anti-CD16/32 and biotinylated antibodies to CD3, B220, and 
Ter119 (all antibodies from Biolegend). Cells were then washed, 
incubated with magnetic beads, and run through a CS column, 
as described above, for bone marrow chimera FACS. The flow 
through from the column was centrifuged, resuspended in 
300 μL FACS buffer, and stained with antibodies to CD11c and 
CD11b. Cells were then washed, resuspended in 500 μL FACS 
buffer, and CD11c+CD11b+ cells sorted by FACS using a FACS 
Aria II cell sorter. OT-II T cells were cultured at 1.0 × 105/100 μL 
in a 96-well flat bottom plate with 1.0 × 104 FACS sorted DCs 
in complete RPMI [10% FCS (Atlas Biologicals, Fort Collins, 
CO, USA) 1% non-essential amino acids, 1% sodium pyruvate, 
1% HEPES, 1% penicillin/streptomycin, and 1% l-glutamine] 
(media and all supplements from Lonza, Walkersville, MD, USA) 
for 72 h. Cell culture supernatants were harvested and analyzed 
using Bio-plex 200 instrument and reagents (Bio-Rad). Anti-Dll4 
antibody and control Ig for cell culture were purified from the 
serum of immunized rabbits using a protein A column (Bio-Rad). 
This antibody has previously been verified to be specific for the 
Notch ligand DLL4 (28).
FigUre 1 | increase in number of cells expressing delta-like 4 in mice infected with Mycobacterium. (a,c,e) Increase in total and dll4+ multipotent 
progenitor cells (lin−ckit+sca1+flt3+), dll4+ splenic DC subsets (pooled together from CD4+CD11c+MHCII+, CD8a+CD11c+MHCII+, and 
CD4−CD8−B220−CD11b+CD11chiMHCII+ populations), and dll4+ lung conventional dendritic cells (autoflourescent−CD11c+CD11b+MHCII+) at 5 weeks post-infection 
with 5.0 × 105 BCG Mycobacterium. Two-way ANOVA indicated that time was a significant factor in our analysis (*p < 0.001). (B,D,F) Flow cytometry histograms 
indicating a slight but non-significant increase in DLL4 expression on the cell surface of MPP, B220−CD11c+MHCII+, and lung dendritic cells at 5 weeks post 
infection. (g) Flow cytometry dot plots depicting total spleen cells from a mouse infected for 5 weeks with BCG, an uninfected mouse from the same time point, and 
an isotype control. (h) Histology of murine lungs at 2, 5, and 10 weeks post-infection. (i) CFU counts from the lung at 2, 5, and 10 weeks post-infection. N = 5 mice 
per group, and the experiment was repeated three times.
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statistical analysis
Analysis was performed using Prism (all figures) or SPSS (all 
tables). In cases where ANOVA analysis indicated that one of 
the independent variables was a significant factor (see Figure 1), 
the cutoff for significance was adjusted to p <  0.001. Principle 
component analysis (PCA) was done using percent of DLL4+ 
TaBle 1 | Principle component analysis of cytokine production in 
response to multiple antigens including PPD, esaT-6, TB4-10, cFP10, 
and ag85a, and Dll4 expression in patients with latent TB infection.
component
antigen specific seB stimulation
ESAT-6 (TNFα) 0.936 0.153
ESAT-6 (IFNγ) 0.925 0.086
PPD (IL-2) 0.875 −0.320
TB10.4 (IL-2) 0.866 0.042
PPD (TNFα) 0.861 −0.333
TB10.4 (IFNγ) 0.860 0.024
ESAT-6 (IL-2) 0.853 0.140
TB10.4 (TNFα) 0.848 0.046
PPD (IFNγ) 0.828 −0.371
Ag85A (IL-2) 0.590 −0.363
DLL4 0.561 −0.267
Ag85A (IFNγ) 0.469 −0.379
CFP-10 (IL-2) −0.037 0.761
CFP-10 (TNFα) −0.014 0.742
SEB (TNFα) 0.431 0.724
SEB (IFNγ) 0.498 0.723
SEB (IL-2) 0.593 0.718
CFP-10 (IFNγ) −0.012 0.717
Ag85A (TNFα) 0.238 −0.306
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monocytes and cytokine production (IL-2, IFNγ, or TNFα) from 
CD4+ T cells in response to specific antigens (Ag85A, CFP10, 
ESAT6, PPD, TB10.4, or Staphylococcus Enterotoxin B) from 
the same donor as individual variables (total of 19 variables per 
donor). After dimension reduction using direct oblimin rotation 
with Kaiser normalization, two components with an Eigenvalue 
≥4 were identified in the cohort of latently infected individuals 
(Table 1). Component normalization indicated these components 
were not related (Table S3 in Supplementary Material).
Patient sample collection and  
animal Welfare
To acquire samples from human patients, this study was carried 
out in accordance with the recommendations of the Human 
Research Ethics Committee at the University of Cape Town 
and the Western Cape Department of Health with written 
informed consent from all subjects. The protocol was approved 
by the Human Research Ethics Committee at the University of 
Cape Town and the Western Cape Department of Health. These 
same de-identified samples were analyzed at the University of 
Michigan under IRB exemption HUM00065150, approved by 
IRBMED. Normal healthy donors were recruited (with written 
informed consent) from the University of Michigan using a 
protocol approved by the IRB committee (HUM00075841). 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki. For animal research, the experi-
ments were carried out with recommendations from the Guide 
for the Care and Use of Laboratory Animals as written by the 
National Institutes of Health, University of Michigan Institutional 
Animal Care and Use Committee (IACUC). The protocol for 
animal use was approved by the University of Michigan IACUC 
(PRO00006469).
resUlTs
We have previously shown that DLL4 is upregulated in the lung 
in response to BCG infection in a TLR9-dependent manner 
(31). Experiments in mice have demonstrated that infec-
tious processes at sites distal to the bone marrow can affect 
stem cell cycling and differentiation (1, 7). We hypothesized 
that mycobacterial infection may also alter the phenotype of 
bone marrow stem and progenitor cells. By investigating sites 
distal to the lung, we were able to determine that there is a 
systemic increase in the percent of cells expressing DLL4+ cells 
as a result of mycobacterial infection. In addition to the lung, 
we observed an increase in DLL4+ cells in spleen and bone 
marrow of infected mice, including all splenic DC subsets and 
bone marrow multipotent progenitors (Figures  1A,C,G). In 
the lung, an increase in DLL4 expression was most prominent 
on CD11b+ dendritic cells (Figures  1E,F), with no increase 
in DLL4 expression observed on alveolar macrophages or 
CD103+ DCs. Although we observed a slight increase in the 
mean fluorescence intensity of DLL4 as a result of infection, 
this did not reach statistical significance (Figures  1B,D,F). 
We observed that the increased DLL4 expression in the 
bone marrow and spleen was correlated with an increase in 
granuloma size and CFUs in the lung (Figures 1H,I). In the 
bone marrow, resolution of infection decreased the amount 
of DLL4 expressed on the surface of multipotent progenitor 
cells. We also observed age-related changes in DLL4 expres-
sion in uninfected mice, a finding that may reflect previous 
research demonstrating changes in Notch ligand expression 
in stromal cells as a result of time in human tissues (34). We 
were able to verify that our antibody was specific for DLL4 
using dendritic cells derived from MxCreDll4ff mice (Figure S1 
in Supplementary Material). We did not observe an increase 
in expression of DLL4 in lymphocyte subsets (B cells, CD4+ 
T cells, and CD8+ T cells), hematopoietic stem cells, or com-
mon myeloid progenitor cells (Figure S2 in Supplementary 
Material). DLL4  +  erythroid progenitors (pre-erythrocyte, 
pro-erythrocyte, or pre-megakaryocyte) were present in very 
low numbers and difficult to distinguish from background 
staining.
To determine if the expression of DLL4 was propagated 
throughout the hematopoietic system as a result of hematopoie-
sis, we isolated DLL4+ and DLL4− Lineage− Sca1+ cKit+ (LSK) 
cells from the bone marrow of BCG-infected mice by FACS. 
Isolated cells were engrafted into lethally irradiated hosts and 
splenocytes were assessed for DLL4 expression at several time 
points post engraftment. We observed a significant increase in 
DLL4 expression in the spleen by flow cytometry on CD11b+ 
MHCII+ cells isolated from recipient mice at 4  weeks post-
engraftment (Figures 2A,B). QPCR from whole spleen demon-
strated a 1.8-fold increase in expression of dll4 at the RNA level 
(Figure 2B). We also observed an increase in DLL4 expression 
in CD11B+MHCII− cells in the spleen; however, the major-
ity of DLL4 expression was found in the MHCII+ population 
(Figures 2C,D). We did not observe an increase in expression of 
DLL4 on lymphocytes in these mice (Figure S3 in Supplementary 
Material). We did not observe an increase in DLL4 expression 
FigUre 2 | Delta-like 4 expression is maintained during short-term hematopoiesis. (a) Flow cytometry plots depicting dll4 and MHCII staining in total 
splenocytes from recipient chimera mice 4 weeks post-engraftment. Donor cells were either dll4+ LSK or dll4− LSK cells isolated from mice infected with 5.0 × 105 
cells at 5 weeks post-infection. Each mouse received 5.0 × 104 LSK cells. (B) QPCR analysis of whole splenocytes for dll4 expression at 4 weeks post-engraftment. 
N = 4 mice per group, and the experiment was repeated two times. (c) Quantification of dll4 expression on B220−CD11B+MHCII+ and B220−CD11B+MHCII− in the 
spleens of chimeric mice. N = 4 mice per group. (D) Flow plots depicting expression of dll4 on B220−CD11B+MHCII− cells as quantified in (c). Gates indicate 
percent of B220−CD11B+MHCII− cells expressing DLL4. For (B,c), Student’s t-test was performed (*p < 0.04). These experiments were repeated two times.
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in mice receiving DLL4+ LSK cells at 7 days post-engraftment 
or at 8 weeks post-engraftment, suggesting that the expression 
of DLL4 as a result of hematopoiesis is transient in the absence 
of BCG infection, and is dependent on donor cell expression of 
this ligand. Using congenic mice, we verified that the majority of 
DLL4 expression was detected on donor cells and not on radio-
resistant recipient cells at 4 weeks post-engraftment (Figure S3 
in Supplementary Material).
FigUre 3 | increased delta-like 4 expression in humans infected with Mtb. (a) Analysis of expression of DLL4 on CD14+ monocytes in individuals diagnosed 
with latent or active M. tuberculosis infection. (B) Flow cytometry plots gated on CD14+ monocytes, depicting dll4 expression of an individual treated for 6 months 
compared to an individual latently infected with Mtb. One-way ANOVA analysis indicated that DLL4 was expression was significantly altered during Mtb infection 
(p = 0.0044).
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We then hypothesized that expression of DLL4 could be 
detected on myeloid cells in the peripheral blood of humans 
with LTBI or active TB disease. As a negative control for these 
experiments, we used PPD negative healthy donors who were 
free of TB disease. Additionally, we tested those patients with 
active TB disease who had been successfully treated for 6 months 
with standard course anti-TB treatment. We found that those 
patients with LTBI or active TB disease had a significant increase 
in DLL4 expression when compared to both active TB patients 
following 6  months of treatment and normal healthy donors 
(Figure 3). When compared to normal healthy donors, this find-
ing was statistically significant when we gated on CD14hi PBMCs 
[F(3,41) = 3.207, p = 0.0044]. Comparison of expression of DLL4 
on total PBMCs in our cohort of patients also resulted in a sta-
tistical significance as determined by ANOVA [F(3,36) = 1.776, 
p = 0.02], but no significant differences were found using Tukey’s 
multiple comparison test.
Notch ligand expression on APCs has been shown to alter 
the host immune response to several pathogens (35–39). For 
example, we have previously demonstrated that T cell-derived 
IL-17 production is increased as a result of Dll4 expression in 
a model of mycobacterial infection (31). To determine if DLL4 
expression altered cytokine production from T cells in humans 
infected with M. tuberculosis, we assessed the CD4 T cell pro-
duction of TNFα, IFNγ, and IL-2 in response to characterized 
mycobacterial antigens including ESAT-6, TB10.4, Ag85A, CFP-
10, and PPD by intracellular cytokine staining in both actively 
and latently infected individuals. We also assessed the produc-
tion of these same cytokines in response to the superantigen 
Staphylococcal Enterotoxin B (SEB) as a positive control. We then 
performed PCA using these data, including the percentage of 
DLL4+ monocytes as a factor to determine if DLL4 expression in 
monocytes was correlated with cytokine production from T cells 
in latently and actively infected individuals. PCA analysis is rou-
tinely used to reduce the number of dimensions in a data set by 
determining if specific variables track together as a component 
(40). Our analysis of latently infected individuals resulted in two 
components each with an Eigenvalue ≥4. The values in Table 1 
state that the correlation between each variable and the two 
discovered principal components on a scale of 1 to −1, with 1 
being a 100% correlation. Values of less than 0.3 are considered 
non-significant. Based on this analysis, we determined that 
DLL4 expression was correlated with cytokine production from 
CD4 T cells as a result of stimulation with specific TB antigens 
including ESAT-6 and PPD in an antigen-specific component. 
The second component contained all of the cytokine data 
FigUre 4 | Delta-like 4 expression correlates with cytokine production from T cells during latent infection. (a) Linear regression analysis of CD4+ T cell 
IFNγ production, as measured by intracellular cytokine staining, compared to the percent of CD14+ monocytes expressing DLL4 in individuals diagnosed with latent 
Mtb infection. Similar results were obtained with IL-2 and TNFα production (Figure S4 in Supplementary Material). (B) Same comparison as (a) in individuals with 
active infection. (c) Production of IFNγ and IL-17 from murine OT-II cells cocultured with OVA peptide and splenic CD11c+CD11b+ FACS sorted from the spleens of 
naïve mice or mice infected for 5 weeks with BCG in the presence of a polyclonal antibody specific to DLL4 or IgG control antibody. Cells were cultured for 72 h in 
the presence of 10 μg/mL anti-DLL4 or control antibody. One-way ANOVA analysis indicated DLL4 was a significant factor in determining cytokine output from T 
cells. For IFNγ, the p value was <0.0001, and for IL-17 the p value was 0.02.
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related to SEB stimulation and was not correlated with DLL4 
expression on monocytes. Interestingly, CFP-10 cytokine 
secretion was associated with the SEB component, suggesting 
a different pattern of cytokine secretion than that induced by 
the other antigens. Based on our component matrix (Table S1 in 
Supplementary Material), which correlates all variables in the 
data set, we determined that DLL4 expression was most closely 
correlated with the cytokine response following stimulation 
with PPD (Table S1 in Supplementary Material). Table S2 in 
Supplementary Material states that the component containing 
SEB cytokine stimulation was not related to the component con-
taining DLL4 expression and cytokine production in response 
to TB antigens. Performing dimension reduction analysis on 
individuals diagnosed with active TB disease did not result in a 
component containing DLL4 expression. This analysis informed 
us that DLL4 expression on monocytes was associated with T 
cell cytokine production in latently infected individuals. We 
then performed linear regression analysis to determine if there 
was a direct correlation between cytokine production and DLL4 
expression in both latent infection and active TB disease. Our 
results indicate an r2 value of 0.54 when correlating the percent of 
CD4+ T cells producing IFNγ and the percentage of monocytes 
expressing DLL4 in response to PPD. There was no correlation 
between DLL4 expression and cytokine production in response 
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to SEB (Figure 4A). There was no correlation between cytokine 
production and DLL4 expression on monocytes in patients with 
active TB disease (Figure  4B). There was also no correlation 
between CD8+ T cell cytokine production and DLL4 expression 
(Table S3 in Supplementary Material). Consistent with previous 
data, there was also reduced frequency of cytokine-producing 
T cells in patients with active TB (33).
To experimentally verify that DLL4 expression on APCs that 
occurs as a result of BCG infection can alter T cell cytokine 
production from naïve T cells, we isolated dendritic cells 
(CD11chiCD11b+) from the spleens of BCG infected mice and 
uninfected controls and cocultured them with T cells isolated 
from RAG2−/− mice carrying the OT-II transgene. Cells were 
stimulated with the peptide OVA323–339 and in the presence of a 
blocking antibody to DLL4 or a control IgG. We observed that 
both IFNγ and IL-17 were increased in cocultures containing 
DCs from BCG-infected mice. This increase in cytokine produc-
tion was reduced when a blocking antibody to DLL4 was added 
to the culture (Figure 4C).
DiscUssiOn
Our data indicate that the number of cells expressing DLL4 
is increased in both early hematopoietic progenitor cells and 
differentiated myeloid cells in the spleen as a result of lung 
mycobacterial infection in mice. This systemic upregulation is 
likely derived both from de novo exposure of immune cells to 
mycobacterial products and from the maintenance of dll4 expres-
sion through hematopoiesis. As a small number of DLL4+ cells 
were derived from DLL4− LSK cells (Figure S3 in Supplementary 
Material), we do not believe that exposure to Mycobacterium or 
mycobacterial products is the only way to induce expression of 
this ligand. Several studies support the notion that low-level 
DLL4 expression is a normal part of the hematopoietic process 
(41, 42). Our data suggest that the number of DLL4+ progenitor 
cells increases as a result of mycobacterial infection, and that 
this increased expression is passed on to the progeny of these 
cells, thus increasing the total amount of DLL4 found within 
the immune system. Therefore, it is likely that there are a small 
number of DLL4+ stem and progenitor cells that exist under 
non-infectious conditions, and these cells will generate DLL4+ 
daughter cells.
Our findings were confirmed using peripheral blood samples 
from a cohort of patients with either latent or active mTB infec-
tion. In both human and mouse, antigen-specific T cell cytokine 
production is influenced by DLL4 on the cell surface of APCs that 
occurs as a result of mycobacterial infection. It has previously 
been reported that certain T cell cytokine responses and expres-
sion of cell surface molecules including CD127 correlate with 
latent and active disease (33, 43–45). Although these changes in 
gene expression hint at a profound change in the innate immune 
system as a result of immune mTB infection, this response has not 
been fully characterized.
As the immune response to PPD is correlated with DLL4 
expression in individuals with LTBI but not active TB infection, 
further study of the Notch system in TB may aid in characteriza-
tion of the differences between immune responses in the setting 
of LTBI and active TB disease. Previous research suggests that 
DLL4 can alter the CD4+ T cell cytokine response and T cell 
survival (24–26, 32, 46, 47). Our current data indicate that DLL4 
expression on APCs influences the T cell immune response dur-
ing mTB infection. Furthermore, we demonstrate that DLL4 is 
upregulated on myeloid progenitor cells as a result of mycobacte-
rial infection, and that this upregulated expression is passed on to 
daughter cells even after the microbial stimulus was removed. As 
we were able to observe a DLL4-dependent increase in OT-II T 
cell cytokine production when stimulating these cells with APCs 
from BCG-infected mice, we believe that the outcome of this 
aspect of trained immunity may extend beyond simple increased 
activation of the innate immune cells. The ability of DLL4 to 
increase the cytokine response of a naïve T cell, and the data we 
present here indicating that expression of this molecule is system 
wide, indicate that the entire immune response is “primed” for 
pathogen exposure.
It is of interest that DLL4 expression did not correlate with 
CD4 cytokine production in patients with active TB disease. This 
warrants further study and may indicate that Notch signaling is 
aberrant in those patients with active disease. One possibility is 
the increase in type 1 IFN pathway that is associated with active 
TB disease (48–51) may alter the expression of Notch ligands on 
the surface of myeloid cells. Type 1 IFN is known to increase in 
dll1 expression in murine macrophages, and this ligand has been 
demonstrated to increase the T cell response to H1N1 influenza 
infection (35). In a model of T cell development, low levels of 
DLL1 and DLL4 expression were found to produce functionally 
distinct outcomes, with DLL4 inducing more expression of Notch 
target genes (52). Therefore, it is possible that the type 1 IFN 
pathway may alter the adaptive immune response to mycobacte-
rial infection through altered Notch ligand expression. Further 
examination of monocytes from patients with active TB disease 
and individuals with LTBI may yield pertinent data on the role 
of Notch ligand expression in the anti-mycobacterial immune 
response.
It is of note that the ESAT-6-specific immune response has 
been documented as differing in both cytokine production and 
frequency of response in infected individuals when compared 
to the PPD-specific immune response (53). It is also possible 
that PPD, as a mix of antigens, elicits a stronger and more 
diverse response than a single antigen including ESAT-6 or 
others. These possibilities may explain why DLL4 expression 
correlates more strongly with one antigenic response than 
another.
The systemic wide upregulation of DLL4 may have effects on 
other cell types besides T cells. For example, macrophages are 
known to respond to Notch signaling with increased activation 
(54, 55). DLL4 is also essential for proper thymocyte development 
from common lymphoid progenitors (56). Therefore, a systemic 
increase in expression of this molecule may alter the host immune 
response in numerous ways that allow for more effective immune 
responses to pathogen challenge. Finally, as DLL4 expression is 
reduced in individuals who have been treated for mycobacterial 
infection, it is possible that the measurement of this ligand in 
peripheral blood will generate a biomarker to distinguish infected 
and uninfected individuals.
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